7 results on '"Booij, Linda"'
Search Results
2. Cohort profile update: The Canadian Maternal-Infant Research on Environmental Chemicals Child Development study (MIREC-CD PLUS).
- Author
-
Fisher, Mandy, Muckle, Gina, Lanphear, Bruce, Arbuckle, Tye E., Braun, Joseph M., Zidek, Angelika, Vélez, Maria P., Lupien, Nicole, Bastien, Stephanie, Ashley-Martin, Jillian, Oulhote, Youssef, Borghese, Michael M., Walker, Mark, Asztalos, Elizabeth, Bouchard, Maryse F., Booij, Linda, Palmert, Mark R., Morrison, Katherine M., Cummings, Elizabeth A., and Khatchadourian, Karine
- Subjects
ENVIRONMENTAL research ,CHILD development ,GROWTH of children ,ENVIRONMENTAL exposure ,NEUROPSYCHOLOGICAL tests ,PRENATAL exposure ,PREGNANCY outcomes - Abstract
Background: The pan-Canadian Maternal-Infant Research on Environmental Chemicals (MIREC) study was established to determine whether maternal environmental chemical exposures were associated with adverse pregnancy outcomes in 2001 pregnant women. Objectives: The MIREC-Child Development (CD PLUS) study followed this cohort with the goal of assessing the potential effects of prenatal exposures on anthropometry and neurodevelopment in early childhood. Population: MIREC families with children between the ages of 15 months and 5 years who had agreed to be contacted for future research (n = 1459) were invited to participate in MIREC-CD PLUS which combines data collected from an online Maternal Self-Administered Questionnaire with biomonitoring and neurodevelopment data collected from two in-person visits. Preliminary Results: Between April 2013 and March 2015, 803 children participated in the Biomonitoring visit where we collected anthropometric measures, blood, and urine from the children. The Behavioural Assessment System for Children-2, Behaviour Rating Inventory of Executive Function, MacArthur-Bates Communicative Development Inventories and the Communication subscale of the Adaptive Behaviour Scale from the Bayley Scales of Infant and Toddler Development-III are available on close to 900 children. There were 610 singleton children who completed in-person visits for neurodevelopment assessments including the Social Responsiveness Scale, Wechsler Preschool Primary Scale of Intelligence-III and NEuroPSYchological assessments (NEPSY). Currently, we are following the cohort into early adolescence to measure the impact of early life exposures on endocrine and metabolic function (MIREC-ENDO). Conclusions: Data collection for the MIREC-CD PLUS study is complete and analysis of the data continues. We are now extending the follow-up of the cohort into adolescence to measure the impact of early life exposures on endocrine and metabolic function (MIREC-ENDO). MIREC-CD PLUS is limited by loss to follow-up and the fact that mothers are predominately of higher socioeconomic status and 'White' ethnicity, which limits our generalizability. However, the depth of biomonitoring and clinical measures in MIREC provides a platform to examine associations of prenatal, infancy and childhood exposures with child growth and development. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Gender and sex in eating disorders: A narrative review of the current state of knowledge, research gaps, and recommendations.
- Author
-
Breton, Édith, Juster, Robert‐Paul, and Booij, Linda
- Published
- 2023
- Full Text
- View/download PDF
4. Transparency and completeness of reporting of depression screening tool accuracy studies: A meta‐research review of adherence to the Standards for Reporting of Diagnostic Accuracy Studies statement.
- Author
-
Nassar, Elsa‐Lynn, Levis, Brooke, Neyer, Marieke A., Rice, Danielle B., Booij, Linda, Benedetti, Andrea, and Thombs, Brett D.
- Subjects
MEDICAL screening ,MENTAL depression ,DATA management ,STANDARD deviations ,SAMPLE size (Statistics) - Abstract
Objectives: Accurate and complete study reporting allows evidence users to critically appraise studies, evaluate possible bias, and assess generalizability and applicability. We evaluated the extent to which recent studies on depression screening accuracy were reported consistent with Standards for Reporting of Diagnostic Accuracy Studies (STARD) statement requirements. Methods: MEDLINE was searched from January 1, 2018 through May 21, 2021 for depression screening accuracy studies. Results: 106 studies were included. Of 34 STARD items or sub‐items, the number of adequately reported items per study ranged from 7 to 18 (mean = 11.5, standard deviation [SD] = 2.5; median = 11.5), and the number inadequately reported ranged from 3 to 17 (mean = 10.1, SD = 2.5; median = 10.0). There were eight items adequately reported, seven partially reported, 11 inadequately reported, and four not applicable in ≥50% of studies; the remaining four items had mixed reporting. Items inadequately reported in ≥70% of studies related to the rationale for index test cut‐offs examined, missing data management, analyses of variability in accuracy results, sample size determination, participant flow, study registration, and study protocol. Conclusion: Recently published depression screening accuracy studies are not optimally reported. Journals should endorse and implement STARD adherence. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Sample size and precision of estimates in studies of depression screening tool accuracy: A meta‐research review of studies published in 2018–2021.
- Author
-
Nassar, Elsa‐Lynn, Levis, Brooke, Neyer, Marieke A., Rice, Danielle B., Booij, Linda, Benedetti, Andrea, and Thombs, Brett D.
- Subjects
SAMPLE size (Statistics) ,MEDICAL screening ,SENSITIVITY & specificity (Statistics) ,MENTAL depression ,CONFIDENCE intervals - Abstract
Objectives: Depression screening tool accuracy studies should be conducted with large enough sample sizes to generate precise accuracy estimates. We assessed the proportion of recently published depression screening tool diagnostic accuracy studies that reported sample size calculations; the proportion that provided confidence intervals (CIs); and precision, based on the width and lower bounds of 95% CIs for sensitivity and specificity. In addition, we assessed whether these results have improved since a previous review of studies published in 2013–2015. Methods: MEDLINE was searched from January 1, 2018, through May 21, 2021. Results: Twelve of 106 primary studies (11%) described a viable sample size calculation, which represented an improvement of 8% since the last review. Thirty‐six studies (34%) provided reasonably accurate CIs. Of 103 studies where 95% CIs were provided or could be calculated, seven (7%) had sensitivity CI widths of ≤10%, whereas 58 (56%) had widths of ≥21%. Eighty‐four studies (82%) had lower bounds of CIs <80% for sensitivity and 77 studies (75%) for specificity. These results were similar to those reported previously. Conclusion: Few studies reported sample size calculations, and the number of included individuals in most studies was too small to generate reasonably precise accuracy estimates. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Predictors of non‐completion of a day treatment program for adults with eating disorders.
- Author
-
Thaler, Lea, Booij, Linda, Burnham, Nuala, Kenny, Samantha, Oliverio, Stephanie, Israel, Mimi, and Steiger, Howard
- Subjects
- *
ANOREXIA nervosa treatment , *TREATMENT of eating disorders , *PERSONALITY , *PATIENT dropouts , *MOTIVATION (Psychology) , *TIME , *TREATMENT duration , *PSYCHOSOCIAL factors , *PATIENT compliance , *BODY mass index , *LOGISTIC regression analysis , *TERMINATION of treatment , *ADULTS - Abstract
Although treatment dropout is common among patients with eating disorders, very few studies have examined predictors of non‐completion in day treatment. We investigated various potential predictors of dropout from adult day treatment. Participants were 295 adult patients with a diagnosis of Anorexia Nervosa (restricting or binge‐eating/purging subtype), Bulimia Nervosa (BN), Other Specified Feeding or Eating Disorder, or Avoidant Restrictive Food Intake Disorder. Predictors included eating‐disorder characteristics, motivation at the commencement of treatment, Body Mass Index (BMI), time spent in treatment and personality dimensions. Logistic regression analyses showed that for patients with a BMI of less than 20 at the start of treatment, low BMI was a significant predictor of staff‐initiated termination due to not meeting weight gain goals. Furthermore, completing less than 6 weeks of treatment was associated with staff‐initiated termination. For the whole sample, those with higher changes in weight over the course of treatment were less likely to terminate prematurely. None of the other predictor variables yielded significant results. Results of the current study highlight characteristics of patients who are more likely not to complete day treatment and can help identify patients who may be at risk for not succeeding in multi‐diagnostic day treatment programs. Highlights: For patients attending day treatment, low BMI at the start of treatment was a significant predictor of staff‐initiated discharge in participants who entered the program with a BMI < 20For all patients, larger changes in BMI over the course of treatment predicted higher likelihood of completing treatmentResults can help identify which patients may be at risk for not succeeding in multi‐diagnostic day treatment programs and address this risk in the transition to a higher level of care from lower levels [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. In‐person versus virtual therapy in outpatient eating‐disorder treatment: A COVID‐19 inspired study.
- Author
-
Steiger, Howard, Booij, Linda, Crescenzi, Olivia, Oliverio, Stephanie, Singer, Ilana, Thaler, Lea, St‐Hilaire, Annie, and Israel, Mimi
- Subjects
- *
TREATMENT of eating disorders , *SELF-evaluation , *PATIENTS , *TREATMENT effectiveness , *COMPARATIVE studies , *TELEMEDICINE , *COVID-19 pandemic , *PSYCHOTHERAPY - Abstract
Objective: Findings show virtual therapy (conducted using internet‐based videoconferencing techniques) to be a viable alternative to in‐person therapy for a variety of mental‐health problems. COVID‐19 social‐distancing imperatives required us to substitute virtual interventions for in‐person sessions routinely offered in our outpatient eating disorder (ED) program—and afforded us an opportunity to compare the two treatment formats for clinical efficacy. Methods: Using self‐report assessments, we compared outcomes in a historical sample of 49 adults with heterogeneous EDs (treated in‐person over 10–14 weeks in individual and group therapies) to those of 76 patients receiving comparable virtual treatments, at distance, during the COVID‐19 outbreak. Linear mixed models were used to study symptom changes over time and to test for differential effects of treatment modality. Results: Participants in both groups showed similar improvements on eating symptoms, levels of weight gain (in individuals in whom gain was indicated), and satisfaction with services. Discussion: Our results suggest that short‐term clinical outcomes with virtual and in‐person ED therapies are comparable, and point to potentials of virtual therapy for situations in which geographical distance or other barriers impede physical access to trained therapists or specialized treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.